South Wales, July 18 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "NADVANCE" on July 9. The details about the trademark application no. UK00004231252 published in the journal no. 2025/029 (July 18).
Omar Awais filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical drugs; Pharmaceuticals; Dermatological pharmaceutical substances; Pharmaceutical preparations for use in oncology; Astringents [pharmaceutical]; Pharmaceutical compositions; Pharmaceutical creams; Pharmaceutical preparations; Pharmaceutical implants; Pharmaceutical preparations and substances for use in oncology; Dermatological pharmaceutical products; Pharmaceutical sweets; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for use in urology; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for use in hematology; Pharmaceutical preparations and substances; Homeopathic pharmaceuticals; Pharmaceutical preparations and substances for use in gynecology; Cardiovascular pharmaceutical preparations; Cytostatics for pharmaceutical purposes; Pharmaceutical lipsalves; Alkaloids used for pharmaceutical purposes; Pharmaceutical preparations for inhalers; Injectable pharmaceuticals; Pastilles for pharmaceutical purposes; Bromine for pharmaceutical purposes; Cellulose for pharmaceutical purposes; Menthol for pharmaceutical purposes; Liquorice for pharmaceutical purposes; Alginates for pharmaceutical purposes; Parenteral anti-epileptic pharmaceutical preparations; Esters for pharmaceutical purposes; Pharmaceutical solutions used in dialysis; Food esters for pharmaceutical purposes; Elixirs [pharmaceutical preparations]; Lotions for pharmaceutical purposes; Capsules for pharmaceutical purposes; Eucalyptol for pharmaceutical purposes; Iodine for pharmaceutical purposes; Ethanol for pharmaceutical purposes; Propolis for pharmaceutical purposes; Anti-diabetic pharmaceuticals; Pharmaceutical products for the treatment of cancer; Gentian for pharmaceutical purposes; Yeast for medical, veterinary or pharmaceutical purposes; Chemicals for pharmaceutical use; Anti-bacterial pharmaceutical preparations; Pharmaceutical preparations for animal skincare; Antidiabetic pharmaceuticals; Ointments for pharmaceutical purposes; Phenol for pharmaceutical purposes; Thymol for pharmaceutical purposes; Pharmaceutical cough preparations; Sandalwood oil for medical, pharmaceutical and veterinary purposes; Iodides for pharmaceutical purposes; Alcohol for pharmaceutical purposes; Pharmaceutical preparations for medical purposes; Pharmaceutical preparations for veterinary use; Chemical preparations for pharmaceutical purposes; Diuretic pharmaceutical preparations; Alginate tablets for pharmaceutical purposes; Antibacterials for pharmaceutical use; Lactose for pharmaceutical purposes; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the treatment of depression; Lozenges for pharmaceutical purposes; Syrups for pharmaceutical purposes; Guaiacol for pharmaceutical purposes; Phosphates for pharmaceutical purposes; Yeast extracts for medical, veterinary or pharmaceutical purposes; Creosote for pharmaceutical purposes; Pharmaceutical antiallergic preparations and substances; Peptones for pharmaceutical purposes; Aldehydes for pharmaceutical purposes; Analgesics for pharmaceutical use; Oral anti-epileptic pharmaceutical preparations; Malt for pharmaceutical purposes; Pharmaceutical preparations for animals; Pectin for pharmaceutical purposes; Starch for pharmaceutical purposes; Magnesia for pharmaceutical purposes; Perilla for pharmaceutical purposes; Eucalyptus for pharmaceutical purposes; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in the field of anesthesia; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment of osteoporosis; Balms for pharmaceutical purposes; Pharmaceutical agents for epidermis; Lupulin for pharmaceutical purposes; Cardiovascular pharmaceuticals; Turpentine for pharmaceutical purposes; Ethers for pharmaceutical purposes; Pharmaceutical for the treatment of erectile dysfunction; Digestives for pharmaceutical purposes; Ergot for pharmaceutical purposes; Cellulose esters for pharmaceutical purposes; Tissue-regenerative pharmaceutical preparations; Pharmaceutical preparations for the treatment of hyperlipidemia; Synthetic peptides for pharmaceutical purposes; Flaxseed for pharmaceutical purposes; Pharmaceutical preparations for ophthalmological use; Lime-based pharmaceutical preparations; Pharmaceutical preparations for the treatment of cancer; Mustard for pharmaceutical purposes; Antibacterial pharmaceuticals; Yeast for pharmaceutical purposes; Acetates for pharmaceutical purposes; Pharmaceutical products and preparations for chloasma; Starch for dietetic or pharmaceutical purposes; Effervescent analgesic pharmaceutical preparations; Decoctions for pharmaceutical purposes; Pharmaceutical preparations for treating hypertension; Alginate solutions for pharmaceutical purposes; Pharmaceutical preparations and substances for the prevention of cancer.
Class 10 : Pharmaceutical instruments; Applicators for pharmaceutical preparations; Autoinjectors for the administration of pharmaceutical preparations.
Class 42 : Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research services; Research and development for the pharmaceutical industry; Research of pharmaceuticals; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical product evaluation; Conducting clinical trials for pharmaceutical products.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004231252
Disclaimer: Curated by HT Syndication.
